India-based hyper-personalized & data-driven wellness platform, Answer Genomics has raised $500K in a pre-series A round funding from Inflection Point Ventures.
The funds will be utilized for supporting Sales and marketing efforts and expanding the talent pool through strategic hiring initiatives.
Additionally, these investments will enable Answer Genomics to continue pioneering advances in genomics and ultimately enhance the well-being of individuals through personalized health insights by sequencing 10K genomes in the next 12 months.
Led by Rahul Ranganathan as CEO, and Dr. Balamurali as CTO, Answer Genomics is a data-driven precision health company dedicated to harnessing the power of multi-omic data to assist individuals in making informed decisions about their health.
Speaking about the investment in Answer Genomics, Vikram Ramasubramanian, Partner, Inflection Point Ventures, said, “Research and development in healthcare has always been of critical importance, with Genomics being at the cutting edge. Data science lends itself very well to Genomics, allowing healthcare companies to provide deep insights, and bio hacks to improve one’s lifestyle quality. As an early mover, Answer Genomics not only addresses an individual’s need for better health but also provides data for large organizations to create better products.”
Commenting on the funding round, Rahul Ranganathan, CEO, of Answer Genomics, says, “The advent of AI is changing the landscape of healthcare. We now possess the technology capable of understanding the human body for the masterpiece that it is. Multi-omnic data collected over time forms a picture of current and future health allowing accurate prognosis, early diagnosis, and precision treatment. We believe precision health would reduce the burden on our healthcare infrastructure by allowing for accurate predictions, remote interventions, and faster recoveries.”
The company has also filed for 2 patents and holds publications papers in important peer-reviewed journals.